Novartis reported $878.25M in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US USD 32.37B 1.03B
Artemis Alpha ATS:LN GBP 373K 0
AstraZeneca AZN:LN USD 387M 0
Bayer BAYN:GR EUR 2.52B 0
Biogen BIIB:US USD 100K 0
Bristol Myers Squibb BMY:US USD 292M 0
Eli Lilly And LLY:US USD 594.1M 0
Fresenius FRE:GR EUR 563M 0
Galapagos GLPG:NA EUR 293.6M 579K
Genmab GEN:DC DKK 66M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Hikma Pharmaceutical HIK:LN USD 41M 1000K
Merck MRK:GR EUR 565M 0
Novartis NOVN:VX USD 878.25M 11.75M
Novartis NVS:US USD 890M 0
Orion ORNBV:FH EUR 92.2M 0
Recordati REC:IM EUR 26.14M 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Roche Holding ROG:VX 107M 53M